CREBBP and acute myeloid leukemia: Recently in the fifth edition of the World Health Organization (WHO) classification of Tumors, the fusion of KAT6A::CREBBP t(8;16) (p11.2;p13.3) was included under the category AML with other defined genetic alterations.